SEC Form 4 · accession 0001144204-17-033934
Alliqua BioMedical, Inc. · ALQA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bradford Barton
Officer — Chief Operating Officer
Period of report
Jun 23, 2017
Accepted (ET)
Jun 26, 2017 · 10:54 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054274
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 23, 2017 | A | 205,715 | $0.00 | A | 526,358 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the Reporting Person's 2016 year-end bonus paid in shares of restricted stock in lieu of cash based on the value of the Issuer's common stock on February 27, 2017. This award is subject to forfeiture until vested, with 100% vesting on September 21, 2017, subject to the Reporting Person's continued service through the applicable vesting date and the terms and conditions of the Alliqua BioMedical, Inc. 2014 Long-Term Incentive Plan and that certain restricted stock award agreement by and between the Issuer and the Reporting Person, effective as of June 23, 2017.